S&P ASX All Technology

US Dollar vs AUD

Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

Get Started

BGLC BioNexus Gene Lab Corporation

0.6108

0.0208 (3.53%)

Last Updated: 05:54:13

Delayed by 15 minutes

Form PRE 14C - Other preliminary information statements

null

BioNexus Gene Lab (NASDAQ:BGLC)
Historical Stock Chart
From Apr 2024 to May 2024

Click Here for more BioNexus Gene Lab Charts.

BioNexus Gene Lab (NASDAQ:BGLC)
Historical Stock Chart
From May 2023 to May 2024

Click Here for more BioNexus Gene Lab Charts.

BioNexus Gene Lab Corporation News

Form 8-K - Current report
Friday 10 May 2024 (4 hours ago) • Edgar (US Regulatory)

BioNexus Gene Lab Corp. Agrees to Invest RM 1.2 million in Ascension Innovation (AISB) to Advance Digital Health Innovation through AI adoption in Healthcare
Friday 19 April 2024 (3 weeks ago) • GlobeNewswire Inc.

Form PRE 14C - Other preliminary information statements
Saturday 27 January 2024 (3 months ago) • Edgar (US Regulatory)

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
Tuesday 23 January 2024 (4 months ago) • Edgar (US Regulatory)

Form 8-K - Current report
Saturday 4 November 2023 (6 months ago) • Edgar (US Regulatory)

Form 8-K - Current report
Friday 8 September 2023 (8 months ago) • Edgar (US Regulatory)

Form 8-K - Current report
Tuesday 25 July 2023 (10 months ago) • Edgar (US Regulatory)

BioNexus Gene Lab Corp. Announces Closing of $5.75 Million Public Offering and Full Exercise of Over-Allotment Option and Uplisting to the Nasdaq Capital Market
Tuesday 25 July 2023 (10 months ago) • GlobeNewswire Inc.

BioNexus Gene Lab Corp. Announces Pricing of $5 Million Public Offering and Uplisting to the Nasdaq Capital Market
Friday 21 July 2023 (10 months ago) • GlobeNewswire Inc.

More BioNexus Gene Lab Corporation News Articles

JP Morgan Chase

Sterling vs AUD

Commonwealth Bank Of Aus...

Australia And New Zealan...

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions